MAPK1 and acute myeloid leukemia: Interestingly, exposure of U937 AML cells (FAB M4/M5) to a combination of ERK inhibitor and oridonin had an opposite effect significant increase in the IC50 in comparison with control cells in which inhibitors were added alone, and no changes in apoptosis.